We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The health insurer Aetna said April 21 that it would not pay for a nerve-stimulating implant the government has approved as a last-ditch treatment for severe depression.
Percutaneous tibial nerve stimulation (PTNS) therapy must be continuous to maintain control of refractory overactive bladder syndrome, according to the findings of a small clinical trial conducted by Dutch researchers.
The FDA April 25 issued its "Guidance on Informed Consent for In Vitro Diagnostic Device Studies Using Leftover Human Specimens That Are Not Individually Identifiable."
Bausch & Lomb is being sued by claimants for recent incidences of Fusarium keratitis, a painful fungal infection that can cause blurred vision and potentially lead to blindness.
PowdermatriX and MediTech are hosting an event this June to explain and explore issues and developments regarding the use of powder technology in the medical devices industry.
Two blood tests for diagnosing latent tuberculosis (TB) infection can each produce fewer false-positive results than the standard tuberculin skin test in patients presumed to be HIV-negative, according to a study in this week's issue of The Lancet.
A remotely-controlled catheter device guided by magnetic fields provides a safe and practical method for delivering radio frequency ablation treatment in the hearts of patients with atrial fibrillation, according to a new study in the April 4, 2006, issue of the Journal of the American College of Cardiology.
Theragenics Corp. has recorded its first profitable quarter since the second quarter of 2003, impacted positively by the acquisition of CP Medical and by a restructuring.